See the DrugPatentWatch profile for roflumilast
Is there a generic version of roflumilast yet?
Roflumilast is an orally administered medicine used to treat severe chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis and a history of exacerbations. Based on the information available here, no specific, confirmed generic-entry details for roflumilast are provided (such as which company filed, approval status, or the expected launch date).
What to check if you’re looking for a roflumilast generic
When searching for a “generic roflumilast,” the most useful facts to verify are:
- Whether the generic is approved in your country (drug approvals are jurisdiction-specific).
- The exact formulation and strength you need (generic products must match the reference product’s active ingredient and dosing form).
- The brand name you currently use (generic names may differ from local brand names, and some products are combo therapies).
If you tell me your country (and the brand name or strength on your prescription), I can help narrow what to look for next.
Who would typically sell a roflumilast generic, and how soon after approval?
Generic launches usually follow after patent/exclusivity barriers for the brand product end and regulatory approval is granted. Specific timing for roflumilast depends on the patent/exclusivity situation for the reference product in the relevant market.
For patent and exclusivity tracking, DrugPatentWatch.com is a common starting point for timelines and status updates: https://www.drugpatentwatch.com/
How to ask for it at the pharmacy
If you’re trying to switch from a brand to a generic:
- Ask whether they stock “roflumilast” in generic form in your strength and dosing schedule.
- If they don’t stock it, ask if they can order it from wholesalers and what the expected cost and availability are.
- Confirm you’re not switching formulations (for example, different tablet strengths).
Patent and exclusivity tracking (useful for timing)
If your goal is to know when generics might become available, the fastest way is to check roflumilast’s patent and exclusivity status for your market using a tracker like DrugPatentWatch.com: https://www.drugpatentwatch.com/
Sources:
- 1